Suppr超能文献

一种能够进行G蛋白介导信号传导但缺乏与抑制蛋白结合能力的多巴胺D2受体突变体。

A dopamine D2 receptor mutant capable of G protein-mediated signaling but deficient in arrestin binding.

作者信息

Lan Hongxiang, Liu Yong, Bell Michal I, Gurevich Vsevolod V, Neve Kim A

机构信息

Department of Physiology & Pharmacology, Oregon Health & Science University, Portland, Oregon, USA.

出版信息

Mol Pharmacol. 2009 Jan;75(1):113-23. doi: 10.1124/mol.108.050534. Epub 2008 Sep 22.

Abstract

Arrestins mediate G protein-coupled receptor desensitization, internalization, and signaling. Dopamine D(2) and D(3) receptors have similar structures but distinct characteristics of interaction with arrestins. The goals of this study were to compare arrestin-binding determinants in D(2) and D(3) receptors other than phosphorylation sites and to create a D(2) receptor that is deficient in arrestin binding. We first assessed the ability of purified arrestins to bind to glutathione transferase (GST) fusion proteins containing the receptor third intracellular loops (IC3). Arrestin3 bound to IC3 of both D(2) and D(3) receptors, with the affinity and localization of the binding site indistinguishable between the receptor subtypes. Mutagenesis of the GST-IC3 fusion proteins identified an important determinant of the binding of arrestin3 in the N-terminal region of IC3. Alanine mutations of this determinant (IYIV212-215) in the full-length D(2) receptor generated a signaling-biased receptor with intact ligand binding and G-protein coupling and activation, but deficient in receptor-mediated arrestin3 translocation to the membrane, agonist-induced receptor internalization, and agonist-induced desensitization in human embryonic kidney 293 cells. This mutation also decreased arrestin-dependent activation of extracellular signal-regulated kinases. The finding that nonphosphorylated D(2)-IC3 and D(3)-IC3 have similar affinity for arrestin is consistent with previous suggestions that the differential effects of D(2) and D(3) receptor activation on membrane translocation of arrestin and receptor internalization are due, at least in part, to differential phosphorylation of the receptors. In addition, these results imply that the sequence IYIV212-215 at the N terminus of IC3 of the D(2) receptor is a key element of the arrestin binding site.

摘要

抑制蛋白介导G蛋白偶联受体脱敏、内化及信号转导。多巴胺D2和D3受体结构相似,但与抑制蛋白相互作用的特征不同。本研究的目的是比较D2和D3受体中除磷酸化位点外的抑制蛋白结合决定因素,并构建一种抑制蛋白结合缺陷的D2受体。我们首先评估了纯化的抑制蛋白与含有受体第三细胞内环(IC3)的谷胱甘肽S-转移酶(GST)融合蛋白的结合能力。抑制蛋白3与D2和D3受体的IC3结合,结合位点的亲和力和定位在受体亚型之间无明显差异。对GST-IC3融合蛋白进行诱变,确定了IC3 N端区域中抑制蛋白3结合的一个重要决定因素。全长D2受体中该决定因素(IYIV212-215)的丙氨酸突变产生了一种信号偏向性受体,其配体结合、G蛋白偶联及激活功能完整,但在人胚肾293细胞中,受体介导的抑制蛋白3向膜的转位、激动剂诱导的受体内化及激动剂诱导的脱敏功能缺陷。该突变还降低了细胞外信号调节激酶的抑制蛋白依赖性激活。非磷酸化的D2-IC3和D3-IC3对抑制蛋白具有相似亲和力这一发现,与之前关于D2和D3受体激活对抑制蛋白膜转位和受体内化的不同影响至少部分归因于受体不同磷酸化的观点一致。此外,这些结果表明,D2受体IC3 N端的序列IYIV212-215是抑制蛋白结合位点的关键元件。

相似文献

1
A dopamine D2 receptor mutant capable of G protein-mediated signaling but deficient in arrestin binding.
Mol Pharmacol. 2009 Jan;75(1):113-23. doi: 10.1124/mol.108.050534. Epub 2008 Sep 22.
2
An intracellular loop 2 amino acid residue determines differential binding of arrestin to the dopamine D2 and D3 receptors.
Mol Pharmacol. 2009 Jan;75(1):19-26. doi: 10.1124/mol.108.050542. Epub 2008 Sep 26.
5
Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor.
J Neurosci. 2002 Oct 1;22(19):8476-86. doi: 10.1523/JNEUROSCI.22-19-08476.2002.
7
Agonist-induced endocytosis and receptor phosphorylation mediate resensitization of dopamine D(2) receptors.
Mol Endocrinol. 2010 Mar;24(3):574-86. doi: 10.1210/me.2009-0369. Epub 2010 Feb 16.
10
The role of phosphorylation in D1 dopamine receptor desensitization: evidence for a novel mechanism of arrestin association.
J Biol Chem. 2004 Feb 27;279(9):7999-8010. doi: 10.1074/jbc.M308281200. Epub 2003 Dec 4.

引用本文的文献

2
An arginine switch drives the stepwise activation of β-arrestin by CXCR7.
PLoS Biol. 2025 Aug 7;23(8):e3003312. doi: 10.1371/journal.pbio.3003312. eCollection 2025 Aug.
4
Receptor activity-modifying protein modulation of parathyroid hormone-1 receptor function and signaling.
Front Pharmacol. 2024 Sep 23;15:1455231. doi: 10.3389/fphar.2024.1455231. eCollection 2024.
5
Biased Dopamine D Receptors Exhibit Distinct Intracellular Trafficking Properties and ERK Activation in Different Subcellular Domains.
Biomol Ther (Seoul). 2024 Jan 1;32(1):56-64. doi: 10.4062/biomolther.2023.033. Epub 2023 Jul 19.
7
Commentary on "Novel Interaction of the Dopamine D2 Receptor and the Ca Binding Protein S100B: Role in D2 Receptor Function".
Mol Pharmacol. 2021 Aug;100(2):61-64. doi: 10.1124/molpharm.121.000284. Epub 2021 May 27.
8
Signaling-Biased and Constitutively Active Dopamine D2 Receptor Variant.
ACS Chem Neurosci. 2021 Jun 2;12(11):1873-1884. doi: 10.1021/acschemneuro.0c00712. Epub 2021 May 11.
9
A Gain-of-Function Variant in Dopamine D2 Receptor and Progressive Chorea and Dystonia Phenotype.
Mov Disord. 2021 Mar;36(3):729-739. doi: 10.1002/mds.28385. Epub 2020 Nov 16.
10
Many faces of the GPCR-arrestin interaction.
Arch Pharm Res. 2020 Sep;43(9):890-899. doi: 10.1007/s12272-020-01263-w. Epub 2020 Aug 14.

本文引用的文献

1
An intracellular loop 2 amino acid residue determines differential binding of arrestin to the dopamine D2 and D3 receptors.
Mol Pharmacol. 2009 Jan;75(1):19-26. doi: 10.1124/mol.108.050542. Epub 2008 Sep 26.
2
Evidence that calmodulin binding to the dopamine D2 receptor enhances receptor signaling.
J Recept Signal Transduct Res. 2007;27(1):47-65. doi: 10.1080/10799890601094152.
3
Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.
J Biol Chem. 2006 Apr 21;281(16):10856-64. doi: 10.1074/jbc.M513380200. Epub 2006 Feb 21.
4
The structural basis of arrestin-mediated regulation of G-protein-coupled receptors.
Pharmacol Ther. 2006 Jun;110(3):465-502. doi: 10.1016/j.pharmthera.2005.09.008. Epub 2006 Feb 3.
5
6
Non-canonical YXXGPhi endocytic motifs: recognition by AP2 and preferential utilization in P2X4 receptors.
J Cell Sci. 2005 Jul 15;118(Pt 14):3073-80. doi: 10.1242/jcs.02451. Epub 2005 Jun 28.
7
Morphine side effects in beta-arrestin 2 knockout mice.
J Pharmacol Exp Ther. 2005 Sep;314(3):1195-201. doi: 10.1124/jpet.105.087254. Epub 2005 May 25.
8
Dopamine D1 receptor interaction with arrestin3 in neostriatal neurons.
J Neurochem. 2005 Apr;93(1):128-34. doi: 10.1111/j.1471-4159.2004.02998.x.
9
Endocytosis of the Nipah virus glycoproteins.
J Virol. 2005 Mar;79(6):3865-72. doi: 10.1128/JVI.79.6.3865-3872.2005.
10
Arrestin2 expression selectively increases during neural differentiation.
J Neurochem. 2004 Dec;91(6):1404-16. doi: 10.1111/j.1471-4159.2004.02830.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验